Citations

Mayo Clinic

Clear

720 citation(s) found for "Núñez, Gabriel".

Lidocaine Patch to Treat Postoperative Tourniquet Pain After Total Knee Replacement: A Case Report
Clark, Brittney M., Pagani-Estévez, Gabriel L., Johnson, Rebecca L.

A&A Practice | July 11, 2018 | Volume: 11 | Issue: 7 | Pages: 173-174

10.1213/xaa.0000000000000772 | PMID 29672324 Get It

Intraoperative tourniquet-related pain is well recognized by anesthesiologists, but postoperative tourniquet-related pain has received little attention. We present a patient who underwent a total knee arthroplasty under general anesthesia and an adductor canal nerve block. She complained of intractable thigh pain postoperatively. Lidocaine 5% patches completely resolved her postoperative tourniquet-related pain.
Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma: 6-Month Outcomes
Salinas, Lauriane, Chaudhary, Ankita, Lazcano-Gómez, Gabriel , Williamson, Blake K. , Dorairaj, Syril , Seibold, Leonard K., Smith, Sanjay, Aref, Ahmad A. , Darlington, Jason K., Jiménez-Román, Jesús, Mahootchi, Ahad , Boucékine, Mohamed , Mansouri, Kaweh , Dorairaj, Syril K., Berdahl, John Palmer

Journal of Glaucoma | July 4, 2018 | Volume: 27 | Issue: 10 | Pages: 849-855

10.1097/ijg.0000000000001019 | PMID 29979337 Get It

Purpose: The purpose of the study is to describe short-term efficacy and safety of goniotomy with trabecular meshwork excision using the Kahook Dual Blade (KDB, New World Medical Inc., Rancho Cucamonga, CA) in patients with severe or refractory glaucoma. Method: Retrospective multicentric case series of 53 eyes with severe or refractory glaucoma as defined by ICD-10 conducted in the United States, Mexico, and Switzerland. Primary efficacy outcome was a ≥20% decrease in intraocular pressure (IOP) from baseline at 6 months. Secondary efficacy outcome measures were probability of achieving an IOP≤14 or 18 mm Hg at 6 months and the mean IOP change from baseline at 6 months. Medication use required to obtain target IOP at last follow up and adverse effects were analyzed. Results: The proportion of eyes achieving an IOP reduction of >20% from preoperative baseline at 6 months was 57.7% (n=30). The mean IOP decreased from 18.4±6.1 mm Hg at baseline to 13.9±3.5 mm Hg at month 6 (23.9% reduction; P<0.001). At 6 months, 63.5% and 92.3% achieved an IOP≤14 and ≤18 mm Hg, respectively, and the mean number of glaucoma medications was reduced by 1.2±1.3 (36.6%) compared with baseline (P<0.001). The most common adverse event was hyphema (n=29, 34.9%) with spontaneous resolution in all cases. No severe complications were reported. One case presented with uncontrolled IOP and required glaucoma drainage device surgery at 1 month. Conclusions: Goniotomy with trabecular meshwork excision using the KDB could be an alternative surgery for severe or refractory glaucoma, significantly reducing IOP and medication use at 6 months, with a low rate of complications.
Single-Kidney Transplant on VA-ECMO While Recovering from Post-Heart-Transplant Graft Failure
Prada, Gabriel , Agarwal, Anjali , Díaz‐Gómez, José L. , Ratzlaff, Robert A. , Díaz-Gómez, José L

Case Reports in Critical Care | June 28, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-3

10.1155/2018/7431265 | PMID 30050699 Get It

Although no consensus exists on whether extracorporeal membrane oxygenation (ECMO) support is an indication for solid-organ transplantation other than heart and lung, this practice continues to be limited. We present a case of a 55-year-old man who was placed on venoarterial ECMO (VA-ECMO) during orthotopic heart transplantation (OHT) because of acute graft failure. Twenty-four hours later, the patient underwent deceased-donor renal transplantation (DDRT) while on VA-ECMO and had no complications. On post-DDRT day 2 (post-OHT day 3), the patient was successfully decannulated from VA-ECMO and ultimately discharged home. This case highlights the potential successful use of ECMO support during solid-organ transplantation other than heart and lung and the importance of trained providers and tailored anticoagulation. To the authors’ knowledge, this is the first report of perioperative ECMO use during kidney transplantation after recent heart transplantation.
Laparoscopic proximal gastrectomy for gastric neoplasms
Kukar, Moshim , Gabriel, Emmanuel , Ben‐David, Kfir , Hochwald, Steven N. , Gabriel, Emmanuel M

Journal of Surgical Oncology | June 19, 2018 | Volume: 118 | Issue: 1 | Pages: 95-100

10.1002/jso.25123 | PMID 29920681 Get It

BackgroundFor cancers of the distal gastroesophageal junction or the proximal stomach, proximal gastrectomy can be performed. It is associated with several perioperative benefits compared with total gastrectomy. The use of laparoscopic proximal gastrectomy (LPG) has become an increasingly popular approach for select tumors.MethodsWe describe our method of LPG, including the preoperative work‐up, illustrated depictions of the key steps of the surgery, and our postoperative pathway.ResultsA total of 6 patients underwent LPG between July, 2013 to June, 2017. Five patients had early‐stage adenocarcinoma, and 1 patient had a gastrointestinal stromal tumor. The median age of the cohort was 70, and each patient had significant comorbidities. Conversion to open was required for 1 patient. All patients had negative final margins and an adequate lymph node dissection (median number of nodes examined was 15, range 12‐22). The median postoperative length of stay was 7 days (range 4‐7). Two patients developed anastomotic strictures requiring intervention, and 1 patient experienced significant reflux. At a median follow‐up of 11 months, there was 1 recurrence. Three patients were alive without evidence of disease, and 2 patients died from other causes.ConclusionsFor carefully selected patients, LPG is a safe and reasonable alternative to total gastrectomy, which is associated with similar oncologic outcomes and low morbidity.
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants
Kumar, Anita J. , Hemmer, Michael, Arora, Mukta , Pidala, Joseph A. , Couriel, Daniel R. , Aljurf, Mahmoud , Cahn, Jean‐Yves, Cairo, Mitchell S. , Farhan, Shatha , Hale, Gregory A., Hashmi, Shahrukh K. , Inamoto, Yoshihiro , Kamble, Rammurti T., Kharfan‐Dabaja, Mohamed A. , MacMillan, Margaret L. , Marks, David I. , Norkin, Maxim , Ringdén, Olle , Schouten, Harry C. , Solh, Melhem , Urbano-Ispizúa, Álvaro , Verdonck, Leo F. , Hamilton, Betty K. , Majhail, Navneet S. , Loren, Alison W. , Ringden, Olov , Majhail, Navneet S , Kim, Soyoung , Spellman, Stephen R. , Alousi, Amin Majid , Cahn, Jean‐Yves , Cutler, Corey S. , Gergis, Usama , Nakasone, Hideki , Qayed, Muna , Schultz, Kirk R. , Teshima, Takanori , Gale, Robert Peter

Blood Advances | May 8, 2018 | Volume: 2 | Issue: 9 | Pages: 1022-1031

10.1182/bloodadvances.2017013052 | PMID 29739773 Get It

Key Points Compared with parous female sibling donors, male URDs confer more aGVHD in all patients and more cGVHD in females. There was no difference in survival, relapse, or transplant mortality between recipients of parous female sibling or male URD grafts.
The Caenorhabditis elegans spe‐49 gene is required for fertilization and encodes a sperm‐specific transmembrane protein homologous to SPE‐42
Wilson, Luke D., Obakpolor, Omoyemwen A., Jones, Autumn M., Richie, Abigail L., Mieczkowski, Bryce D., Fall, Gabriel T., Hall, Rosine W., Rumbley, Jon N. , Kroft, Tim L.

Molecular Reproduction and Development | April 25, 2018 | Volume: 85 | Issue: 7 | Pages: 563-578

10.1002/mrd.22992 | PMID 29693775 Get It

Fertilization, the fusion of sperm and oocyte to form a zygote, is the first and arguably the most important cell–cell interaction event in an organism’s life. Forward and reverse genetic approaches in the nematode Caenorhabditis elegans have identified many genes that are required for gametogenesis and fertilization and thus are beginning to elucidate the molecular pathways that underlie these processes. We identified an allele of the spe‐49 gene in a second filial generation (F2) mutagenesis screen for spermatogenesis‐defective (spe) mutants. Mutant worms for spe‐49 produce sperm that have normal morphology, activate to form ameboid spermatozoa, and can migrate to and maintain their position in the hermaphrodite reproductive tract but fail to fertilize oocytes. This phenotype puts spe‐49 in the spe‐9 class of late‐acting genes that function in sperm at the time of fertilization. We cloned the spe‐49 gene through a combination of deficiency mapping, transgenic rescue, and genomic sequencing. spe‐49 messenger RNA (mRNA) is enriched in male germ cells, and the complementary DNA (cDNA) encodes a predicted 772‐amino‐acid six‐pass transmembrane protein that is homologous to SPE‐42. Indeed, SPE‐49 and SPE‐42 have identical predicted membrane topology and domain structure, including a large extracellular domain with six conserved cysteine residues, a DC‐STAMP domain, and a C‐terminal cytoplasmic domain containing a C4–C4 RING finger motif. The presence of two SPE‐42 homologs in animal genomes from worms to humans suggests that these proteins are highly conserved components of the molecular apparatus required for the sperm–oocyte recognition, binding, and fusion.
Rediscovering the Orbit of Percutaneous Coronary Intervention After ORBITA
Bhatt, Deepak L. , Steg, Philippe Gabríel , Harrington, Robert A. , Windecker, Stephan , Bhatt, Deepak L , Gersh, Bernard J. , Steg, P Gabriel , Windecker, Stephan

Circulation | April 18, 2018 | Volume: 137 | Issue: 23 | Pages: 2427-2429

10.1161/circulationaha.118.034596 | PMID 29669787 Get It

Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia
Sharma, Rishi , Chakraborty, Tia , Pureza, Vincent , Pagani-Estevez, Gabriel L., Buadi, Francis K. , Pureza, Vincent S, Beam, Elena , Pagani-Estévez, Gabriel L., Flanagan, Eoin P.

Neurology | April 16, 2018 | Volume: 90 | Issue: 16 | Pages: 748-752

10.1212/wnl.0000000000005337 | PMID 29661894 Get It

Intravital microscopy in the study of the tumor microenvironment: from bench to human application
Fisher, Daniel T., Evans, Sharon S. , Skitzki, Joseph J. , Gabriel, Emmanuel M, Gabriel, Emmanuel , Takabe, Kazuaki

Oncotarget | April 13, 2018 | Volume: 9 | Issue: 28 | Pages: 20165-20178

10.18632/oncotarget.24957 | PMID 29732011 Get It

Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
Orozco, Carlos A. , Martínez‐Bosch, Neus , Guerrero, Pedro Enrique , Vinaixa, Judith , Dalotto‐Moreno, Tomás , Iglesias, Mar , Moreno, Mireia , Djurec, Magdolna, Poirier, Françoise, Fernández-Zapico, Martín E. , Hwang, Rosa F. , Guerra, Carmen , Navarro, Pilar , Navarro, Pilar , Gabius, Hans‐Joachim , Rabinovich, Gabriel A

Proceedings of the National Academy of Sciences | April 3, 2018 | Volume: 115 | Issue: 16 | Pages: No page available

10.1073/pnas.1722434115 | PMID 29615514 Get It

Significance Pancreatic ductal adenocarcinoma (PDA) is the third leading of cause of cancer death in the United States and is predicted to be the second one by 2030. The tumor microenvironment is a major source of soluble mediators that influence tumor progression and hinder the success of therapeutic strategies. Using a genetically engineered mouse model and human cell-based systems, we identify galectin-1 (Gal1) as a critical soluble factor capable of regulating tumor–stroma crosstalk promoting proliferation, angiogenesis, and modulation of inflammatory responses, resulting in enhanced tumor development and metastasis. Our data provide an integrated view of the role of Gal1 in the PDA microenvironment and reinforce the high therapeutic value of Gal1 inhibition in PDA treatment.